Author:
Doyle Carolyn A.,McDougle Christopher J.
Publisher
Springer International Publishing
Reference14 articles.
1. Carminati, G. G., Deriaz, N., et al. (2006). Low-dose venlafaxine in three adolescents and young adults with autistic disorder improves self-injurious behavior and attention deficit/hyperactivity disorders (ADHD)-like symptoms. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30(2), 312–315.
2. Cook, E. H., Jr., Rowlett, R., et al. (1992). Fluoxetine treatment of children and adults with autistic disorder and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 31(4), 739–745.
3. Findling, R. L., Schwartz, M. A., et al. (1996). Venlafaxine in adults with attention-deficit/hyperactivity disorder: An open clinical trial. The Journal of Clinical Psychiatry, 57(5), 184–189.
4. Findling, R. L., Greenhill, L. L., et al. (2007). Venlafaxine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 17(4), 433–445.
5. Gordon, C. T., State, R. C., et al. (1993). A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Archives of General Psychiatry, 50(6), 441–447.